InterMune Divests Actimmune to Vidara Therapeutics
CATEGORIES Asian Capabilities Capital Raising Commercial Assessment ARCHIVE InterMune Divests Actimmune to Vidara Therapeutics The Locust Walk team is proud […]
News
News
2011 Year End Review
CATEGORIES News Events Publications ARCHIVE 2011 Year End Review Dear Friends & Colleagues We hope you are enjoying the holiday
News
Locust Walk Announces Launch of Broker Dealer
CATEGORIES News Events Publications ARCHIVE Locust Walk Announces Launch of Broker Dealer Locust Walk announced today the formation of a
Events, News, Publications
The Potential Valeant Coup
CATEGORIES News Events Publications ARCHIVE The Potential Valeant Coup Nine years ago while I was working at a bulge bracket
News
Locust Walk Partners Update
CATEGORIES News Events Publications ARCHIVE Locust Walk Partners Update Dear Friends & Colleagues: We wanted to take the opportunity to
News
Locust Walk’s Geoff Meyerson named as one of Philadelphia Business Journal’s “40 Under 40”
CATEGORIES News Events Publications ARCHIVE Locust Walk’s Geoff Meyerson named as one of Philadelphia Business Journal’s “40 Under 40” Locust
News
Out of Whack: Biotech Business Development Compensation
CATEGORIES News Events Publications ARCHIVE Out of Whack: Biotech Business Development Compensation Biotech business development is out of whack! Something
News
Negotiate the Exit Before the Entry – Part 3
CATEGORIES News Events Publications ARCHIVE Negotiate the Exit Before the Entry – Part 3 Today I listened to a very
Events, News, Publications
Locust Walk Partners – 2009 Wrap-up
CATEGORIES News Events Publications ARCHIVE Locust Walk Partners – 2009 Wrap-up The Locust Walk Partners team is thrilled to have
Events, News, Publications
Gloucester Pharmaceuticals’ Istodax® (romidepsin) Receives FDA Approval to Treat Cutaneous T-cell Lymphoma
CATEGORIES News Events Publications ARCHIVE Gloucester Pharmaceuticals’ Istodax® (romidepsin) Receives FDA Approval to Treat Cutaneous T-cell Lymphoma I am pleased